Predictive Biosciences Announces Partnership With ARUP Laboratories
Published: Apr 02, 2013
LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences today announced a partnership with ARUP Laboratories, a national reference laboratory and enterprise of the University of Utah, to offer the company’s molecular diagnostic bladder cancer tests to ARUP’s national network of clients. Through a non-exclusive agreement, ARUP will offer Predictive’s CertNDxTM Bladder Cancer Assays in its comprehensive test menu to leading hospitals, healthcare providers, academic medical centers and military and government facilities around the country. ARUP’s clients will be able to order CertNDx testing, submit samples and receive all results through ARUP. Predictive Biosciences will run the diagnostic testing in its CAP and CLIA-certified laboratory.